Overview This page contains the latest trade data of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts. In 2023, Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts were the world's 141st most traded product, with a total trade of $23.1B. Between 2022 and 2023 the exports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts grew by 70.3%, from $13.5B to $23.1B. Trade in Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts represent 0.1% of total world trade.
Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts are a part of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and....
Exports In 2023 the top exporters of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts were Ireland ($11.1B), United States ($5.26B), Switzerland ($3.45B), Denmark ($1.46B), and Argentina ($669M).
Imports In 2023 the top importers of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts were United States ($8.81B), Italy ($5.53B), Austria ($3.53B), Germany ($2.44B), and China ($1.47B).
Ranking Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts ranks 465th in the Product Complexity Index (PCI).